Pharmaceutical Companies shift from Small Molecule Drugs to Biotech Drugs

Recently, the Tufts University’s Center for the Study of Drug Development (CSDD) released an interesting report revealing the dramatic shift of pharmaceutical companies from manufacturing small molecule drugs to a large number of biotechnology drugs. The report shows that in…

More Details
ViaCyte: Regenerative Medicine and Cell Therapy Derived from Stem Cells

ViaCyte Inc. is emerging as a leader in regenerative medicine and is all set to develop a new approach for the treatment of major diseases using cell therapy derived from stem cells. The company was granted 28 patents in 2011-2013…

More Details
‘Fire In the Blood’ – An Eye Opener for Patent Law Makers in Pharmaceuticals

Fire in the Blood, is a documentary on “medicine, monopoly and malice.” It tells the story of how Western pharmaceutical companies and governments blocked access to low-cost AIDS drugs for the countries of the global south in the years after…

More Details
MSDx Patents on Detection and monitoring of Multiple Sclerosis

Major aim of MSDx, Inc. is to commercialize In vitro Diagnostics (IVD) and Research Use Only (RUO) blood test products used in checking autoimmune and neurological disorders. The company was recently granted patent by United States Patent and Trademark Office…

More Details
Playing with Patent Law: Profit Making Scheme

On June 13, 2013 Supreme Court of US ordered that naturally occurring genes and the information encoded by them will not be patented, though artificially synthesized ones can be. The issue came to picture when patent was filed by Myriad…

More Details
Sunshine in oncology therapeutics – “Extended Dicer Substance”

Dicerna pharmaceutical is working as a new hope for the people suffering from cancer and other lethal diseases. Dicerna being a biopharmaceutical company uses RNA interference (RNAi) to treat cancer by their new introduced Dicer substrate technology™ platform and encore™…

More Details
Indiana farmer’s fight over soybean seeds

A fight over soybean seeds being practiced between a southern Indiana farmer and Monsanto is closely observed in Northwest Indiana and across the country. The Supreme Court takes Monsanto Co.’s side in its claim that Bowman’s violated the company’s patent…

More Details
X